118 related articles for article (PubMed ID: 6137525)
1. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
[No Abstract] [Full Text] [Related]
2. Transient neonatal hyperthyroidism and maternal thyroid stimulating immunoglobulins.
Matsuda T; Momoi T; Akaishi K; Yagura T; Kasagi K; Endo K
Arch Dis Child; 1988 Feb; 63(2):205-7. PubMed ID: 2894819
[TBL] [Abstract][Full Text] [Related]
3. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
4. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
5. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
6. Placental transmission of thyroid-stimulating immunoglobulins.
Dirmikis SM; Munro DS
Br Med J; 1975 Jun; 2(5972):665-6. PubMed ID: 1173561
[TBL] [Abstract][Full Text] [Related]
7. Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies.
Takeda K; Takamatsu J; Kasagi K; Sakane S; Ikegami Y; Isotani H; Majima T; Majima M; Kitaoka H; Iida Y
Clin Endocrinol (Oxf); 1988 Apr; 28(4):341-4. PubMed ID: 2903804
[TBL] [Abstract][Full Text] [Related]
8. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
Munro DS; Dirmikis SM; Humphries H; Smith T; Broadhead GD
Br J Obstet Gynaecol; 1978 Nov; 85(11):837-43. PubMed ID: 581471
[No Abstract] [Full Text] [Related]
9. Thyroid-stimulating immunoglobulins and thyroid function tests in two siblings with neonatal thyrotoxicosis.
Wit JM; Rees-Smith B; Creagh FM; Bruinse HW; van der Heide D; Docter R; Gerards LJ
Eur J Pediatr; 1986 Apr; 145(1-2):143-7. PubMed ID: 2874029
[TBL] [Abstract][Full Text] [Related]
10. Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).
Mitchell I; Shenfield G; Brash J
Arch Dis Child; 1976 Jul; 51(7):565-7. PubMed ID: 962368
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
12. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
Munro DS
J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
[No Abstract] [Full Text] [Related]
13. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
Connors MH; Styne DM
Pediatrics; 1986 Aug; 78(2):287-90. PubMed ID: 2874542
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of measuring thyroid receptor antibodies, thyroid-stimulating and thyroid stimulation-blocking antibodies.
Sasaki N; Tamaru K; Tsuyusaki T; Inomata H; Niimi H; Nakajima H
Acta Paediatr Jpn; 1988; 30 Suppl():133-8. PubMed ID: 2906202
[No Abstract] [Full Text] [Related]
15. The role of long acting thyroid stimulator in neonatal thyrotoxicosis.
Maisey MN; Stimmler L
Clin Endocrinol (Oxf); 1972 Jan; 1(1):81-90. PubMed ID: 4677121
[No Abstract] [Full Text] [Related]
16. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
17. Failure to produce experimental autoimmune thyrotoxicosis in rabbits immunized with thyroidal microsomes.
Wall JR; Good BF; Hetzel BS
Aust J Exp Biol Med Sci; 1973 Oct; 51(5):703-6. PubMed ID: 4787506
[No Abstract] [Full Text] [Related]
18. [Thyroid-stimulating antibodies].
Kandror VI; Ibragim MD
Probl Endokrinol (Mosk); 1985; 31(4):75-80. PubMed ID: 2864686
[No Abstract] [Full Text] [Related]
19. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
20. Immunological features of nonimmunogenic hyperthyroidism.
Grubeck-Loebenstein B; Derfler K; Kassal H; Knapp W; Krisch K; Liszka K; Smyth PP; Waldhäusl W
J Clin Endocrinol Metab; 1985 Jan; 60(1):150-5. PubMed ID: 2856880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
